Atlas Trials

Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT07296627 · RECRUITING

Trial details

NCT number
NCT07296627
Sponsor
Peking University People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Newly Diagnosed Multiple Myeloma (NDMM)
Start date
2025-07-16
Primary completion
2027-07-15
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.